RxDoctor Payments Data

Amanda Watkins

Family · Corbin, KYNPI 1215913298

Payments from drug & device makers

$2,556in general payments, 2019–2025

Across 155 payments — averaging $16.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$578
  • Merck$509
  • Pfizer$371
  • Novartis$308
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$258
  • Amgen$101
  • plus $432 from 8 others

What the payments were for

  • Food & beverage$2,45696%
  • Education$1014%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,556 in reported general payments places this provider in the 80th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$28,707
Medicare patients
116
Services billed
389

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Repatha SureclickEvolocumab60$75,437
EliquisApixaban53$52,851
EntrestoSacubitril/Valsartan42$42,189
BrilintaTicagrelor12$8,463
Ranolazine ErRanolazine19$7,170
Metoprolol Succinate175$1,085
Rosuvastatin Calcium62$387
Isosorbide Mononitrate ErIsosorbide Mononitrate57$367
Lisinopril49$330
Losartan Potassium34$330
Atorvastatin Calcium74$326
Carvedilol50$313
Hydralazine Hcl29$267
Amlodipine Besylate88$234
Propranolol Hcl13$224

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$371$52,85153 claims
NovartisEntresto$308$42,18942 claims
AstraZenecaBrilinta$578$8,46312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,374 family providers in Kentucky.

Other family in Corbin

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →